| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Internal Medicine, Justus-Liebig-University Giessen, 35392 Giessen, Germany
Hypoxic pulmonary vasoconstriction (HPV) matches lung perfusion with ventilation but may also result in chronic pulmonary hypertension. It has not been clarified whether acute HPV and the response to prolonged alveolar hypoxia are triggered by identical mechanisms. We characterized the vascular response to sustained hypoxic ventilation (3% O2 for 120-180 min) in isolated rabbit lungs. Hypoxia provoked a biphasic increase in pulmonary arterial pressure (PAP). Persistent PAP elevation was observed after termination of hypoxia. Total blockage of lung nitric oxide (NO) formation by NG-monomethyl-L-arginine caused a two- to threefold amplification of acute HPV, the sustained pressor response, and the loss of posthypoxic relaxation. This amplification was only moderate when NO formation was partially blocked by the inducible NO synthase inhibitor S-methylisothiourea. The superoxide scavenger nitro blue tetrazolium and the superoxide dismutase inhibitor triethylenetetramine reduced the initial vasoconstrictor response, the prolonged PAP increase, and the loss of posthypoxic vasorelaxation to a similar extent. The NAD(P)H oxidase inhibitor diphenyleneiodonium nearly fully blocked the late vascular responses to hypoxia in a dose that effected a decrease to half of the acute HPV. In conclusion, as similarly suggested for acute HPV, lung NO synthesis and the superoxide-hydrogen peroxide axis appear to be implicated in the prolonged pressor response and the posthypoxic loss of vasorelaxation in perfused rabbit lungs undergoing 2-3 h of hypoxic ventilation.
hypoxic pulmonary vasoconstriction; pulmonary hypertension; nitric oxide
This article has been cited by other articles:
|
|
 |
|
  N. Weissmann, S. Hackemack, B. K. Dahal, S. S. Pullamsetti, R. Savai, M. Mittal, B. Fuchs, T. Medebach, R. Dumitrascu, M. v. Eickels, et al. The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice Am J Physiol Lung Cell Mol Physiol, October 1, 2009; 297(4): L658 - L665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Janssen Isoprostanes and Lung Vascular Pathology Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 383 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. T. Ward Curiouser and curiouser: the perplexing conundrum of reactive oxygen species and hypoxic pulmonary vasoconstriction Exp Physiol, September 1, 2007; 92(5): 819 - 820. [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. T. Ward Point:Counterpoint: Hypoxic pulmonary vasoconstriction is/is not mediated by increased production of reactive oxygen species J Appl Physiol, September 1, 2006; 101(3): 993 - 995. [Full Text] [PDF]
|
|
|
|
|
|
N. Weissmann, S. Zeller, R. U. Schafer, C. Turowski, M. Ay, K. Quanz, H. A. Ghofrani, R. T. Schermuly, L. Fink, W. Seeger, et al. Impact of Mitochondria and NADPH Oxidases on Acute and Sustained Hypoxic Pulmonary Vasoconstriction Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 505 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Q. Liu, I. N. Zelko, E. M. Erbynn, J. S. K. Sham, and R. J. Folz Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox) Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L2 - L10. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Du, M. Frazier, T. J. McMahon, and J. P. Eu Redox Activation of Intracellular Calcium Release Channels (Ryanodine Receptors) in the Sustained Phase of Hypoxia-Induced Pulmonary Vasoconstriction Chest, December 1, 2005; 128(6_suppl): 556S - 558S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Weigand, J. Foxson, J. Wang, L. A. Shimoda, and J. T. Sylvester Inhibition of hypoxic pulmonary vasoconstriction by antagonists of store-operated Ca2+ and nonselective cation channels Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L5 - L13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Khoo, L. Zhao, N. J. Alp, J. K. Bendall, T. Nicoli, K. Rockett, M. R. Wilkins, and K. M. Channon Pivotal Role for Endothelial Tetrahydrobiopterin in Pulmonary Hypertension Circulation, April 26, 2005; 111(16): 2126 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Olschewski, Z. Hong, D. A. Peterson, D. P. Nelson, V. A. Porter, and E. K. Weir Opposite effects of redox status on membrane potential, cytosolic calcium, and tone in pulmonary arteries and ductus arteriosus Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L15 - L22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Nozik-Grayck, Y.-C. T. Huang, M. S. Carraway, and C. A. Piantadosi Bicarbonate-dependent superoxide release and pulmonary artery tone Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2327 - H2335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Girgis, D. Li, X. Zhan, J. G. N. Garcia, R. M. Tuder, P. M. Hassoun, and R. A. Johns Attenuation of chronic hypoxic pulmonary hypertension by simvastatin Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H938 - H945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Weissmann, F. Grimminger, A. Olschewski, and W. Seeger Hypoxic pulmonary vasoconstriction: a multifactorial response? Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L314 - L317. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
